Log In
Print
BCIQ
Print
Print this Print this
 

alisertib (MLN8237)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionSecond-generation aurora kinase A (AURKA) inhibitor
Molecular Target Aurora kinase A (AURKA) (Aurora-A)
Mechanism of ActionAurora kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today